2025 Research | Soft Tissue Sarcoma Market to Reach USD 2.57 Billion by 2030, Fueled by Innovations in Treatments and Rising Cancer Prevalence
17. Januar 2025 07:49 ET
|
Research and Markets
Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Soft Tissue Sarcoma Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...
Sarcoma Drugs Strategic Industry Research Report 2023-2024 & 2030, Competitive Profiles of 42 Players Including Amgen, Bayer, Eisai, Eli Lilly, Johnson and Johnson, Novartis, Pfizer Inc.
03. Dezember 2024 08:48 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Sarcoma Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Sarcoma Drugs was...
Ewing Sarcoma Drug Pipeline Market Research 2024: Insights About 25+ Companies and 25+ Pipeline Drugs
19. April 2024 07:22 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Ewing Sarcoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Ewing Sarcoma - Pipeline Insight,...
US Kaposi's Sarcoma Market and Competitive Landscape Report 2021-2026: Pipeline Products, Epidemiology, Market Valuations and Forecasts, Drugs Sales
31. Mai 2021 07:48 ET
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "US Kaposi's Sarcoma Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Kaposi's Sarcoma Market and...